FIELD: chemical-pharmaceutical industry, pulmonology. SUBSTANCE: invention relates to composition used for treatment of patients with respiratory distress-syndrome. Proposed composition for treatment of newborns with respiratory distress-syndrome and acute respiratory distress-syndrome has at least a single glucocorticosteroid and a single pulmonary surface-active substance. EFFECT: significantly decreased treatment period and lethality caused by syndromes. 8 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
POLYPEPTIDES SHOWING ACTIVITY OF PULMONARY SURFACE-ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2145611C1 |
METHOD OF TREATMENT OF ADULT PATIENTS WITH RESPIRATORY DISTRESS SYNDROME | 1999 |
|
RU2149016C1 |
METHOD OF PROPHYLAXIS OF PNEUMONIA AND RESPIRATORY DISTRESS- -SYNDROME IN ADULT PATIENTS IN ASPIRATION OF STOMACH CONTENT | 1999 |
|
RU2149018C1 |
METHOD FOR TREATING ACUTE RESPIRATORY DISTRESS-SYNDROME | 2003 |
|
RU2265434C2 |
TREATMENT OF NEWBORNS WITH POSTNATAL PNEUMONIA | 1999 |
|
RU2149015C1 |
METHOD FOR DIAGNOSING ACUTE RESPIRATORY DISTRESS SYNDROME | 2000 |
|
RU2187962C2 |
METHOD OF TREATMENT OF CHILDREN WITH RESPIRATORY INSUFFICIENCY AT CRITICAL STATES | 1999 |
|
RU2149017C1 |
SUBSTITUTED AMINOALKYLAMINOPYRIDINES AND DRUG ON SAID | 1994 |
|
RU2135492C1 |
METHOD OF PREDICTING DURATION OF ARTIFICIAL LUNG VENTILATION IN PATIENTS WITH SYNDROME OF ACUTE LUNG INJURY | 2012 |
|
RU2497442C2 |
METHOD FOR EVALUATING DYNAMIC COURSE OF RESPIRATORY DISTRESS SYNDROME | 1997 |
|
RU2153282C2 |
Authors
Dates
2000-10-10—Published
1995-09-27—Filed